Corona: DCGI approves Cipla, will be able to import Moderna’s vaccine for emergency use

DGCI has approved for the emergency use of the Corona vaccine by the American company Moderna. Cipla will now be able to import this vaccine into India. Sources have confirmed this. Moderna is the fourth vaccine approved in India after Covishield, Covaccine and Sputnik V.

DCGI has given approval for the emergency use of the Corona vaccine by the American company Moderna. Cipla will now be able to import this vaccine into India. Also Read Uproar over India’s purchase of Covaxin, Brazil’s President in trouble

Sources have confirmed this. Moderna is the fourth vaccine to be approved in India after Covishield, Covaccine and Sputnik V. Mumbai-based pharma company Cipla also sought approval for the import and market authorization of Moderna Vaccine, which has been approved by DCGI. Let us tell you that DCGI had relaxed the rules for foreign vaccines on 1 June itself. DCGI had told that if a vaccine has been approved by the US, Europe, UK, Japan or WHO, then it does not need to conduct breeding trials in India. Also Read Announcement of new project of Karan Johar, film will be made on Jallianwala Bagh Massacre

Moderna has already received approval from the World Health Organization (WHO). According to WHO, Moderna’s vaccine is up to 94.1% effective against Corona. The WHO says that 14 days after the first dose of Moderna Vaccine, the risk of getting corona is reduced by 94.1%.

It is worth noting that apart from Moderna, Pfizer’s vaccine can also be approved soon. Recently, Pfizer CEO Albert Bourla told in an event that the process of approval of Pfizer’s vaccine in India is in the final stage and soon the company can finalize the agreement with the Indian government.

Spread the love

Leave a Reply

Your email address will not be published. Required fields are marked *

Back To Top